Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Dermatol. argent ; 17(3): 240-242, mayo-jun. 2011. ilus
Article in Spanish | LILACS | ID: lil-724166

ABSTRACT

Presentamos a una mujer de 75 años, con antecedente de psoriasis a grandes placas, de 40 años de evolución. Luego de múltiples tratamientos tópicos y sistémicos que mejoraron su dermatosis, se observaron placas amarillo-anaranjadas infiltradas, de localización paravertebral. El estudio histopatológico informó la presencia de adipocitos maduros en banda en dermis reticular. Se realizó el diagnóstico de metaplasia lipomatosa. En la piel, la metaplasia lipomatosa es sumamente infrecuente. Se postula que la metaplasia puede ocurrir como consecuencia de la inflamación crónica y severa de la piel.


We report the case of a 75 year-old woman who had been suffering from severe large-plaquepsoriasis during forty years. After multiple topical and systemic treatments her psoriasisimproved and yellowish-orange, dorsal, infiltrated plaques were observed.Histology of skin biopsies showed a band of mature adipocytes in the reticular dermis. Thediagnosis of lipomatous metaplasia was considered.Lipomatous metaplasia of the skin is very infrequent. Up to date, we have found only onereport, in which the authors hypothesize that it can occur as a consequence of severe chronic inflammation of the skin.


Subject(s)
Humans , Aged , Female , Metaplasia/etiology , Adipose Tissue/pathology , Inflammation/complications , Lipomatosis/etiology , Lipomatosis/drug therapy , Skin/pathology , Psoriasis/complications
2.
Dermatol. argent ; 16(2): 126-128, mar.-abr. 2010. ilus
Article in Spanish | LILACS | ID: lil-714930

ABSTRACT

Staphylococcus aureus es un patógeno que causa infecciones de diversa gravedad en niños y adultos. Su frecuencia es alta (28,4 casos por cada 100.000 personas). En los últimos años reemerge como patógeno de infecciones severas de piel y partes blandas en pacientes de la comunidad, con características feno y genotípicas diferentes; se lo denomina Staphylococcus aureus meticilino-resistente adquirido en la comunidad (SAMRAC). En nuestro país constituye un patógeno emergente subdiagnosticado. Se presenta una familia que durante 1 año consultó por múltiples episodios de infecciones cutáneas recidivantes, tratadas con esquemas antibióticos empíricos, sin aislamiento microbiológico y fracaso terapéutico. Se observaron nódulos eritematosos, algunos con centro necrótico y ulcerados, en diversas localizaciones. El cultivo de las lesiones de los 3 pacientes confirmó el diagnóstico de SAMRAC. Los hisopados nasales fueron negativos. Realizaron tratamiento con trimetoprima-sulfametoxazol 800/160 mg cada 12 hs y clindamicina 300 mg cada 6hs por 14 días, con curación total de las lesiones


Staphylococcus aureus is a pathogen responsible for infections of variableseverity both in children and adults. Its prevalence is high (about28.4 cases per 100.000 persons). Nowadays this pathogen cause severeskin and soft tissue infections in the community setting. Neverthelessits features are different and has been denominated communityacquired meticiline resistant S. aureus (CA-SAMR). In our countrythis pathogen is under diagnosed.We describe a family with multiple episodes of recidivate skin infectionswhich were treated empirically and without success. The clinical featurewas the presence of eritemathous nodules, some of them ulcerated andnecrotic, in diff erent sites. CA-SAMR was isolated in all patients. Nasalsamples were negative in all family members. They were treated with trimetoprimsulfamethoxazol 800/160 mg each 12 hours and clindamicine300 each 6 hours for 14 days with complete cure of the lesions. (DermatolArgent 2010;16(2):126-128).


Subject(s)
Humans , Male , Adult , Child , Female , Community-Acquired Infections/diagnosis , Community-Acquired Infections/microbiology , Community-Acquired Infections/drug therapy , Staphylococcus aureus , Staphylococcus aureus/genetics , Clindamycin/administration & dosage , Trimethoprim, Sulfamethoxazole Drug Combination/administration & dosage , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL